Masroor Muhammad, Haque Zeba
Dow University of Health Sciences, Karachi, Pakistan.
J Clin Transl Hepatol. 2021 Feb 28;9(1):15-21. doi: 10.14218/JCTH.2019.00046. Epub 2021 Jan 2.
Multiple non-invasive methods including radiological, anthropometric and biochemical markers have been reported with variable performance. The present study assessed glycosylated hemoglobin (HbA) as a biomarker to predict non-alcoholic fatty liver disease (NAFLD) and its severity, compared with body mass index (BMI), waist to hip ratio (WHR) and waist circumference (WC).
This case control study included 450 individuals, including 150 cases and 300 age- and gender-matched controls recruited from the Dow Radiology Institute on the basis of radiological findings of fatty infiltration on abdominal ultrasound through convenient sampling. BMI, WHR and WC were measured according to standard protocols. HbA was determined by turbidimetric inhibition immunoassay.
Among the cases and controls, 66% and 32% had HbA levels higher than 5.7% respectively. HbA and BMI were significantly associated with NAFLD [crude odds ratio (cOR)=4.12, 2.88, 2.25 (overweight) and 4.32 (obese)]. WC was found to be significantly associated with NAFLD for both genders (cOR in males=5.50 and females=5.79, <0.01). After adjustment for other parameters, HbA and WC were found to be significantly associated with NAFLD (aOR=3.40, <0.001) along with WC in males (aOR=2.91, <0.05) and in females (aOR=4.28, <0.05). A significant rise in severity of hepatic steatosis was noted with increases in HbA, BMI and WC. HbA possessed a positive predictive value of 76% for the study population [0.76, confidence interval (CI): 0.715-0.809], 70.6% for males (0.706, CI: 0.629-0.783) and 80% for females (0.80, CI: 0.741-0.858).
Higher than normal HbA and WC measurements possess a more than 70% potential to predict NAFLD. It is the single risk factor that is strongly associated with NAFLD after adjustment for indices of body measurements. HbA may be presented as a potential biomarker for NAFLD in examination with other anthropometric measures in the adult population.
已有多种非侵入性方法被报道,包括放射学、人体测量学和生化标志物,但它们的表现各不相同。本研究评估糖化血红蛋白(HbA)作为预测非酒精性脂肪性肝病(NAFLD)及其严重程度的生物标志物,并与体重指数(BMI)、腰臀比(WHR)和腰围(WC)进行比较。
本病例对照研究纳入450名个体,其中包括150例病例和300例年龄及性别匹配的对照,这些个体是通过方便抽样从道放射学研究所招募的,招募依据是腹部超声检查发现的脂肪浸润放射学结果。根据标准方案测量BMI、WHR和WC。通过比浊抑制免疫测定法测定HbA。
在病例组和对照组中,分别有66%和32%的个体HbA水平高于5.7%。HbA和BMI与NAFLD显著相关[粗比值比(cOR)=4.12、2.88、2.25(超重)和4.32(肥胖)]。发现WC与男女两性的NAFLD均显著相关(男性cOR=5.50,女性cOR=5.79,<0.01)。在对其他参数进行调整后,发现HbA和WC与NAFLD显著相关(调整后比值比[aOR]=3.40,<0.001),男性WC(aOR=2.91,<0.05)和女性WC(aOR=4.28,<0.05)也与NAFLD显著相关。随着HbA、BMI和WC的升高,肝脂肪变性的严重程度显著增加。HbA对研究人群的阳性预测值为76%[0.76,置信区间(CI):0.715 - 0.809],男性为70.6%(0.706,CI:0.629 - 0.783),女性为80%(0.80,CI:0.741 - 0.858)。
高于正常水平的HbA和WC测量值预测NAFLD的潜力超过70%。在对身体测量指标进行调整后,它是与NAFLD密切相关的单一危险因素。在成人人群的检查中,HbA可作为与其他人体测量指标一起用于NAFLD的潜在生物标志物。